Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shareholders are probably feeling a little disappointed, since its shares fell 7.7% to US$35.98 in the week after its latest first-quarter results.

The discovery of a trove of rare earth elements is potentially a major turn of fortunes for this small mining company.

The Golden State Warriors did something they haven't done in 18 years during Saturday's Game 3 against the Minnesota ...

Coin collecting is a hobby that has been around for years. Chances are that you may have a relative or know someone who's an ...

The Colorado Buffaloes are looking to build their recruiting class of 2026. Colorado coach Deion Sanders and the Buffaloes ...

Minnesota blasted Golden State in Game 2, and Butler didn't seem terribly interested in, if even capable of, doing much about ...

Hard Asset Management Highlights Historical Resilience and Strong 2025 Market Performance SAN JUAN, PUERTO RICO, May 9, 2025 /EINPresswire / - ...

Democrats are desperate to find a solid candidate to challenge U.S. Sen. Susan Collins in 2026. It could be Jared Golden.

Jayson Tatum's torn Achilles tendon, without hyperbole, is among the most consequential injuries in NBA history. Kevin Durant ...

After moving up his commitment date from April 30 to May 13, Cantwell took an unofficial visit to Georgia, which also hosted ...

Dome Mill: A large-scale central processing facility currently operating below capacity levels. Based on the Technical Report ...

Proposed GOP cuts to federal funding could severely impact Medicaid, as Missouri’s past budget crisis illustrates what's at ...